Deka Bank Deutsche Girozentrale Sangamo Therapeutics, Inc Transaction History

Deka Bank Deutsche Girozentrale

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	BUY	$5.23 - $7.82 $36,610 - $54,740	7,000 Added 10.01%	76,900 $456,000
Q4 2021 Feb 02, 2022	BUY	$7.29 - $10.97 $14,580 - $21,940	2,000 Added 2.95%	69,900 $548,000
Q4 2020 Mar 12, 2021	SELL	$9.23 - $18.18 $31,382 - $61,812	-3,400 Reduced 4.77%	67,900 $1.19 Million
Q3 2020 Oct 29, 2020	BUY	$9.38 - $12.48 $668,794 - $889,824	71,300 New	71,300 $695,000
Q4 2019 Feb 04, 2020	SELL	$8.03 - $11.7 $591,811 - $862,290	-73,700 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $712,235 - $961,714	-78,700 Reduced 51.64%	73,700 $677,000
Q2 2019 Aug 01, 2019	BUY	$8.75 - $13.03 $837,375 - $1.25 Million	95,700 Added 168.78%	152,400 $1.61 Million
Q1 2019 May 10, 2019	BUY	$7.72 - $12.81 $81,060 - $134,505	10,500 Added 22.73%	56,700 $1.03 Million
Q4 2018 Feb 12, 2019	SELL	$9.51 - $16.6 $99,855 - $174,300	-10,500 Reduced 18.52%	46,200 $489,000
Q3 2018 Nov 09, 2018	SELL	$13.05 - $19.05 $19,575 - $28,575	-1,500 Reduced 2.58%	56,700 $0
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $278,000 - $396,000	20,000 Added 52.36%	58,200 $809,000
Q1 2018 May 03, 2018	BUY	$16.7 - $26.35 $637,940 - $1.01 Million	38,200 New	38,200 $753,000

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.